Cloning and Characterization of the Human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 Gene Promoters

Philip A. Gregory, Dione Gardner-Stephen, Rikke Lewinsky, Kym N. Duncliffe, Peter I. Mackenzie

Journal of Biological Chemistry · 2003 · 30 citations · 51 references

DOIFull text

Open access

Concepts

Abstract

The human UDP-glucuronosyltransferases, UGT1A8, 1A9, and 1A10, are closely related in sequence and have a major role in the elimination of lipophilic chemicals by glucuronidation. UGT1A8 and 1A10 are expressed exclusively in the gastrointestinal tract, whereas UGT1A9 is expressed mainly in the liver and kidneys. To determine the factors contributing to the extrahepatic expression of these UDP-glucuronosyltransferases, we have cloned and characterized the promoters of the UGT1A8, 1A9, and 1A10 genes and studied their regulation in the colon cell line, Caco2. Their transcription start sites were mapped, and a functional overlapping Sp1/initiator-like site was identified which strongly contributed to UGT1A8 and 1A10 promoter activity. The high promoter activity of UGT1A8 and 1A10 correlated with the binding of nuclear proteins (complex B) to this region. Two-bp differences in the corresponding site in the UGT1A9 promoter prevented the binding of complex B and reduced promoter activity. Although Sp1 was able to bind to the Sp1/initiator-like site, its binding was dispensable for promoter activity. However, the binding of Sp1 to a second Sp1 site 30 bp 5′ to the Sp1/initiator-like site greatly enhanced the activity of the UGT1A8 and 1A10 promoters. These results provide evidence that the UGT1A8, 1A9, and 1A10 genes are differentially regulated through an initiator element in their 5′-flanking regions. The human UDP-glucuronosyltransferases, UGT1A8, 1A9, and 1A10, are closely related in sequence and have a major role in the elimination of lipophilic chemicals by glucuronidation. UGT1A8 and 1A10 are expressed exclusively in the gastrointestinal tract, whereas UGT1A9 is expressed mainly in the liver and kidneys. To determine the factors contributing to the extrahepatic expression of these UDP-glucuronosyltransferases, we have cloned and characterized the promoters of the UGT1A8, 1A9, and 1A10 genes and studied their regulation in the colon cell line, Caco2. Their transcription start sites were mapped, and a functional overlapping Sp1/initiator-like site was identified which strongly contributed to UGT1A8 and 1A10 promoter activity. The high promoter activity of UGT1A8 and 1A10 correlated with the binding of nuclear proteins (complex B) to this region. Two-bp differences in the corresponding site in the UGT1A9 promoter prevented the binding of complex B and reduced promoter activity. Although Sp1 was able to bind to the Sp1/initiator-like site, its binding was dispensable for promoter activity. However, the binding of Sp1 to a second Sp1 site 30 bp 5′ to the Sp1/initiator-like site greatly enhanced the activity of the UGT1A8 and 1A10 promoters. These results provide evidence that the UGT1A8, 1A9, and 1A10 genes are differentially regulated through an initiator element in their 5′-flanking regions. Glucuronidation represents one of the major pathways through which the body is able to deactivate and excrete a wide range of lipophilic compounds including drugs, environmental pollutants, dietary chemicals, and endogenous compounds such as bilirubin, steroids, and bile acids (1Dutton G.J. Glucuronidation of Drugs and Other Compounds. CRC Press Inc., Boca Raton, FL1980Google Scholar). Accommodation of such a structurally diverse range of chemicals is provided by the superfamily of UDP-glucuronosyltransferase (UGT) 1The abbreviations used are: UGT, UDP-glucuronosyltransferase; EMSA, electrophoretic mobility shift assay; GABP, GA-binding protein; RACE, RNA ligase-mediated rapid amplification of cDNA ends; TF, transcription factor; USF, upstream stimulatory factor; wt, wild-type; YY1, ying-yang 1. enzymes, of which there are 16 known functional enzymes in humans to date. UGTs are classified into two families, UGT1 and UGT2, based on their amino acid sequence similarity (2Mackenzie P.I. Owens I.S. Burchell B. Bock K.W. Bairoch A. Belanger A. Fournel-Gigleux S. Green M. Hum D.W. Iyanagi T. Lancet D. Louisot P. Magdalou J. Chowdhury J.R. Ritter J.K. Schachter H. Tephly T.R. Tipton K.F. Nebert D.W. Pharmacogenetics. 1997; 7: 255-269Crossref PubMed Scopus (1013) Google Scholar). The UGT2 family is subdivided further into UGT2A and UGT2B subfamilies, each encompassing genes encoded by six unique exons located on chromosome 4 (3Monaghan G. Clarke D.J. Povey S. See C.G. Boxer M. Burchell B. Genomics. 1994; 23: 496-499Crossref PubMed Scopus (56) Google Scholar, 4Turgeon D. Carrier J.S. Levesque E. Beatty B.G. Belanger A. Hum D.W. J. Mol. Biol. 2000; 295: 489-504Crossref PubMed Scopus (76) Google Scholar). In contrast, the UGT1A subfamily is encoded by a single gene locus on chromosome 2, recently shown to span >200 kb (5Gong Q.H. Cho J.W. Huang T. Potter C. Gholami N. Basu N.K. Kubota S. Carvalho S. Pennington M.W. Owens I.S. Popescu N.C. Pharmacogenetics. 2001; 11: 357-368Crossref PubMed Scopus (261) Google Scholar). Eight functional UGT1A enzymes have been shown to be expressed in humans (UG1A1, 1A3, 1A4, 1A6, 1A7, 1A8, 1A9, and 1A10), and four pseudogenes (1A2, 1A11, 1A12, and 1A13) have been identified (6Tukey R.H. Strassburg C.P. Annu. Rev. Pharmacol. Toxicol. 2000; 40: 581-616Crossref PubMed Scopus (1304) Google Scholar). Each UGT1A form contains a unique exon 1, which is joined to a shared set of exons 2–5 through RNA splicing. Characterization of the UGT1A locus has shown that the first exon of each individual form is organized in series upstream from exon 2 (5Gong Q.H. Cho J.W. Huang T. Potter C. Gholami N. Basu N.K. Kubota S. Carvalho S. Pennington M.W. Owens I.S. Popescu N.C. Pharmacogenetics. 2001; 11: 357-368Crossref PubMed Scopus (261) Google Scholar, 7Ritter J.K. Chen F. Sheen Y.Y. Tran H.M. Kimura S. Yeatman M.T. Owens I.S. J. Biol. Chem. 1992; 267: 3257-3261Abstract Full Text PDF PubMed Google Scholar). The first exons are separated from each other by 5′-flanking regions of 5–23 kb in length. Much accumulated evidence suggests that the 5′-flanking of each UGT1A exon contains promoter of their of the promoters of the human and genes that were functional in liver and colon P. H. B. Mol. Pharmacol. PubMed Scopus Google Scholar). on the and genes have shown that their promoter regions are of transcription in liver S. Iyanagi T. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, Ritter J.K. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). In UGT1A genes have recently been to be by the nuclear and through binding to their promoter regions S. Iyanagi T. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, J. H. A. S. Q.H. Owens I.S. M. T. 2001; PubMed Scopus Google Scholar, T. M. Ritter J.K. Bock K.W. PubMed Scopus (56) Google Scholar, A. R.H. S. A. PubMed Scopus Google Scholar, C. C. C. B. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). The of UGT1A expression has been an of Although the liver is to be the major site of the of the gastrointestinal in the of chemicals has been shown by the expression of UGT1A enzymes in these R.H. Strassburg C.P. Mol. Pharmacol. 2001; PubMed Scopus Google Scholar). The liver is known to the UGT1A 1A3, 1A4, 1A6, and J.K. Owens I.S. J. Biol. Chem. Full Text PDF PubMed Google Scholar, B. P.I. PubMed Scopus Google Scholar, D. Fournel-Gigleux S. Burchell B. S. A. PubMed Scopus Google Scholar, T. Clarke D. Burchell B. J. PubMed Scopus Google the 1A7, 1A8, and 1A10 These are expressed exclusively in extrahepatic in the of the gastrointestinal B. P.I. PubMed Scopus Google Scholar, C.P. R.H. Mol. Pharmacol. 1997; PubMed Scopus Google Scholar, C.P. R.H. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, A. Tephly T.R. PubMed Scopus Google Scholar). The functional UGT1A genes are into two the of genes in their first exon sequence and to the other UGT1A genes the (5Gong Q.H. Cho J.W. Huang T. Potter C. Gholami N. Basu N.K. Kubota S. Carvalho S. Pennington M.W. Owens I.S. Popescu N.C. Pharmacogenetics. 2001; 11: 357-368Crossref PubMed Scopus (261) Google Scholar). the which have in expression in the gastrointestinal tract, to be expressed in these C.P. N. R.H. Mol. Pharmacol. Google Scholar, C.P. S. J. P. A. R.H. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). unique of expression of the gene suggests that of regulation be for their the human and genes to transcription T. M. Ritter J.K. Bock K.W. PubMed Scopus (56) Google Scholar, Clarke D. Burchell B. PubMed Scopus Google Scholar). However, of gene transcription by RNA through initiator regions in the promoters of of transcription are the first the binding of transcription to located bp upstream from the transcription start site, and of a complex RNA G. T. D. PubMed Scopus Google Scholar). In contrast, the of transcription through initiator regions is regions are in and promoters and the transcription start site 1997; PubMed Scopus Google Scholar). The initiator site is for transcription transcription is enhanced through upstream Sp1 binding sites J. D. S. A. PubMed Scopus Google Scholar, D. Full Text PDF PubMed Scopus Google Scholar, A. J. Biol. Chem. 1992; 267: Full Text PDF PubMed Google Scholar). Although the sequence of initiator sites to a represents a A. B. Mol. Biol. 1994; PubMed Scopus Google Scholar). The of the initiator site to be enhanced by the of further the site A. B. Mol. Biol. 1994; PubMed Scopus Google Scholar, PubMed Scopus Google Scholar). wide range of proteins has been to bind to sites including J. 1994; PubMed Scopus Google Scholar, M.W. PubMed Scopus Google Scholar, M. Mol. Biol. PubMed Scopus Google RNA J. D. S. A. PubMed Scopus Google ying-yang E. T. PubMed Scopus Google Scholar, A. J. Biol. Chem. Full Text PDF PubMed Google upstream H. J. PubMed Scopus Google Scholar, M. P. PubMed Scopus Google Scholar, 7: Google Sp1 A. J. Biol. Chem. Full Text PDF PubMed Google M. P. PubMed Scopus Google Scholar, Mol. Biol. PubMed Google Mol. Biol. PubMed Scopus Google GA-binding proteins M. T. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google C. G. D. J. 1994; PubMed Scopus Google Scholar, C. T. PubMed Scopus Google and of the family C.P. J. PubMed Scopus Google Scholar, E. H. J. 1994; PubMed Scopus Google Scholar). However, is which factors the binding of proteins to initiator To the contributing to the regulation of the genes in extrahepatic we have cloned and characterized the promoters of each gene and studied their regulation in the colon cell Caco2. The transcription start sites of UGT1A8, 1A9, and 1A10 were mapped, and a overlapping Sp1/initiator-like site was identified which strongly contributed to UGT1A8 and 1A10 promoter activity. of transcription through was for these of the UGT1A8, 1A9, and 1A10 and UGT1A8, 1A9, and 1A10 promoter regions were from a human of for their a was from exon of the UGT1A8 to and with by the from were and as in the was in a of and for 4 with were in 2 for and in for 30 by to with were and by and for from the UGT1A start sites were the RNA ligase-mediated rapid amplification of cDNA to cDNA from RNA RNA was from the of RNA was with and acid to the RNA was with the provided and to the of UGT1A8, 1A9, and 1A10 was by a exon and the The used were as for 4 by of for 30 for 30 for and for acid was to the of the To the UGT1A8, 1A9, and 1A10 were with of the the provided and and 1A10 exon the UGT1A8 for 30 1A9, and 1A10 with of and for 30 were with the and cloned into the to the were and to the of each transcription start of kb of the UGT1A8 and 1A10 promoters were from the by and cloned into the and sites of the The used for the were the and with the The kb of the UGT1A9 promoter was the and and cloned into a site in the of the was by the by two overlapping and into with and The has and sites the and in the UGT1A8, 1A9, and 1A10 Sp1/initiator-like were the with the and shown in are by gene and the the the which was with the and The bp of the UGT1A8 promoter was by the and The upstream Sp1 site was by the and The were cloned into the and sites of the used to promoter and The UGT1A8, 1A9, and 1A10 promoters were by the and with the and were cloned into the The and upstream Sp1 regions were the and with the and cloned into the in the UGT1A8, 1A9, and 1A10 Sp1/initiator-like regions were the and to the are by a and the sites used for are of the UGT1A8, 1A9, and 1A10 promoters and of transcription binding bp of the UGT1A8, 1A9, and 1A10 promoters were from the in in the UGT1A9 and 1A10 genes with the UGT1A8 gene are with a with the and with a The transcription start sites of each gene are with a The Sp1 initiator binding site, and the are differences the overlapping Sp1/initiator-like site have been and from the were in with of amino acids from and in were into a of and the with of promoter and of the 2 to the the were in of and was for and activity the was a and and were from as by E. P. PubMed Scopus Google Scholar). The of the UGT1A8, 1A9, and 1A10 used for are shown in and were by and by with and through were with of nuclear of and in a and for on of was to the which was for a further 30 were the of were in on and complex B bind to the UGT1A8 Sp1/initiator-like region. corresponding to the UGT1A8 Sp1/initiator-like and were with of nuclear and on a The two major and are with of the of the used in are are with a and the are by the The overlapping Sp1/initiator-like site is Sp1 site upstream from the Sp1/initiator-like site UGT1A8 promoter activity. a promoter the bp of the UGT1A8 promoter was as promoter of a upstream Sp1 site was as a with a in the Sp1 site of the and promoter was into with of the as an of were and for and are expressed as a the a of The results shown are a of two individual in the was with of nuclear and on a were a the of The Sp1 was the of and for 30 The two major and are with of the of the and are are with a and the Sp1 is by the The site is Characterization of the UGT1A8, 1A9, and 1A10 The promoter regions of the UGT1A8, 1A9, and 1A10 genes were from a human by with a UGT1A8 exon were and identified as the UGT1A8, 1A9, 1A10 exon by of the kb of the UGT1A8, 1A9, and 1A10 promoters a high of sequence similarity with an of the promoter to the start of each a two Sp1 binding sites as as differences in has been by (5Gong Q.H. Cho J.W. Huang T. Potter C. Gholami N. Basu N.K. Kubota S. Carvalho S. Pennington M.W. Owens I.S. Popescu N.C. Pharmacogenetics. 2001; 11: 357-368Crossref PubMed Scopus (261) Google that the as a for the UGT1A8, 1A9, and 1A10 To this the transcription start sites of the genes were RNA ligase-mediated to the second of which was for UGT1A8, 1A9, 1A10, the was cloned into the and the sequence of the UGT1A8 were with two transcription start sites and bp from the two transcription start sites were for the gene and bp from the the UGT1A9 one transcription start site was identified from bp from the The of the transcription start sites was bp from the that an a be in UGT1A8, 1A9, and 1A10 Although initiator sites A. B. Mol. Biol. 1994; PubMed Scopus Google were an was overlapping the Sp1 binding site in the promoters the UGT1A8 and 1A10 promoters from the UGT1A9 promoter in four the overlapping Sp1/initiator-like we to this nuclear proteins in to the UGT1A8, 1A9, and 1A10 corresponding to to of the UGT1A8 promoter from the start were and with nuclear from the cell in were to the in the UGT1A9 and 1A10 genes and with the UGT1A8 shown in two major and B) were the UGT1A8 and The to form the as the whereas the the complex and the are four differences in sequence the UGT1A8 and genes in this 1, one 2 UGT1A8 and To determine which of these differences the binding were the as shown in of in the UGT1A8 gene on the binding of nuclear proteins of 2 to the of complex B complex of the of complex B and the of complex this is for complex B of 4 in the UGT1A8 gene the of complex and the mobility of complex B. of and 4 in the UGT1A8 gene in the of to by that complex and B is on and 4 is by that the in the UGT1A9 gene in to on The on and were to on and of and 4 in the gene in complex These results that and 4 are for complex and B in the UGT1A8 and 1A10 genes and that differences in these in the UGT1A9 gene the of complex B. we to the and 4 differences in the Sp1/initiator-like of UGT1A8, 1A9, and 1A10 genes their promoter in the UGT1A8, 1A9, and 1A10 activity of the kb of the UGT1A8, 1A9, and 1A10 promoters was by of into the cell that the UGT1A8 and promoters are a activity of and the In contrast, the UGT1A9 promoter a activity To determine the differences and 4 in the Sp1/initiator-like promoter were the used in the of in the of the UGT1A8 and promoters UGT1A8 promoter activity from to UGT1A9 promoter activity from to of 4 UGT1A8 promoter activity to and UGT1A9 promoter activity to of UGT1A8 and promoter activity to and and UGT1A9 promoter activity to These results that the Sp1/initiator-like is for promoter activity of the UGT1A8, 1A9, and 1A10 genes and that differences in binding to this the and UGT1A9 genes with their promoter activity. The promoter activity of the UGT1A8 and 1A10 genes to in by the complex B on the Sp1/initiator-like the of this complex results in promoter activity. the promoter activity of UGT1A9 to in by the of complex B this complex is able to form the promoter activity is we the Sp1/initiator-like the proteins in and B. Sp1 in of the UGT1A8, 1A9, and 1A10 determine Sp1 was able to bind to the UGT1A8, 1A9, and 1A10 Sp1/initiator-like were with the UGT1A8, 1A9, and 1A10 a shown in of the Sp1 reduced the of complex complex B with the and the and and and The in complex was with the the mobility of complex was to that of the complex on the Sp1 that complex in the UGT1A8, 1A9, and 1A10 genes contains Sp1 and that complex B this These were by and Sp1 of a of the the of and B whereas of an of the Sp1 the of complex and In each the were and binding to the These results that complex with the and are and on the binding of Sp1 and B to in the UGT1A8 that and 4 are for complex and B and that complex contains Sp1 that Sp1 and complex B were binding to overlapping regions of the Sp1/initiator-like site and that complex B of To this were in the regions and to the site to the binding of complex B and in of 4 in the Sp1 binding and complex B with the of in the complex B and binding of the Sp1 complex these results that Sp1 binding is on of the Sp1/initiator-like site, complex B is on the of the Sp1/initiator-like site, and that binding to their overlapping sites is To determine the of the proteins complex and were and to known initiator binding In the site to closely and sites in the and promoters A. J. Biol. Chem. Full Text PDF PubMed Google Scholar, N.K. Basu A. J. Biol. Chem. 1992; 267: Full Text PDF PubMed Google Scholar). However, to these factors and the binding proteins and the of the proteins in complex B be of Sp1 to the for UGT1A8 of the UGT1A8, 1A9, and 1A10 promoters and their and 4 that the binding of complex B was for promoter activity To determine the binding of Sp1 to the Sp1/initiator-like site was for UGT1A8 promoter an Sp1 corresponding to the UGT1A8 in was and in with the the promoter activity which the in complex B binding to this promoter These that complex B in the of Sp1 is for UGT1A8 promoter activity. The of the UGT1A8 on the by an Sp1 30 from the has been that the UGT1A8, 1A9, and 1A10 as a in their transcription (5Gong Q.H. Cho J.W. Huang T. Potter C. Gholami N. Basu N.K. Kubota S. Carvalho S. Pennington M.W. Owens I.S. Popescu N.C. Pharmacogenetics. 2001; 11: 357-368Crossref PubMed Scopus (261) Google Scholar). However, that UGT1A8 and 1A10 are strongly regulated through the Sp1/initiator-like which is of In the UGT1A8, 1A9, and 1A10 promoters have a Sp1 site located 30 bp upstream from the functional Sp1/initiator-like Sp1 sites are to the activity of promoters D. Full Text PDF PubMed Scopus Google Scholar, A. J. Biol. Chem. 1992; 267: Full Text PDF PubMed Google Scholar, D. S. A. PubMed Scopus Google Scholar). to determine the of the and the upstream Sp1 site in UGT1A8 and 1A10 bp of the promoters was cloned into the and in The promoter the upstream Sp1 site and Sp1/initiator-like the upstream shown in the UGT1A8 a activity of the was with the promoter suggests that the Sp1/initiator-like is of UGT1A8 and 1A10 promoter activity in the of the of in the upstream Sp1 site upstream the activity of the UGT1A8 and 1A10 promoters to to that this site is in UGT1A8 and 1A10 The of the upstream Sp1 site was by that of this site in the of the UGT1A8 promoter in an in promoter activity The binding of Sp1 to the upstream Sp1 site was by shift with a corresponding to the upstream Sp1 site The of two major with the upstream Sp1 and was The of was reduced by a of upstream Sp1 and Sp1 of an of the upstream Sp1 the of complex complex that complex was on the Sp1 site The of Sp1 in complex was by the of complex complex with a Sp1 these results that the UGT1A8 and 1A10 promoters are regulated through an overlapping Sp1/initiator-like site, which is on an upstream Sp1 site, and to be The UGT1A gene locus represents a unique in which functional UGT1A enzymes are encoded by a exon to a shared set of exons The expression of the UGT1A genes to be regulated by promoter in the their first To the promoter of the human has been characterized The promoter contains a functional of a region. The has been shown to and the with the activity of the promoter E. T. A. S. A. PubMed Scopus Google Scholar). of the and promoters suggests that these genes have a in a to that of the gene J.K. Chen F. Sheen Y.Y. Tran H.M. Kimura S. Yeatman M.T. Owens I.S. J. Biol. Chem. 1992; 267: 3257-3261Abstract Full Text PDF PubMed Google their is to be In this we have characterized the promoters of the UGT1A8, and genes and have shown that an overlapping Sp1/initiator-like site their activity located upstream from the overlapping Sp1/initiator-like site was for UGT1A8 and 1A10 promoter that these promoters are to be in In of this an Sp1 binding site upstream from the overlapping site, a of was to be for UGT1A8 and 1A10 promoter activity. However, is that the as a to the UGT1A8, 1A9, and 1A10 promoters in other cell the high of sequence similarity the UGT1A8, 1A9, and 1A10 promoters the activity of the UGT1A8 and 1A10 promoters were shown to be the UGT1A9 promoter in the colon cell The in promoter activity correlated with the binding of complex B to the Sp1/initiator-like site in the UGT1A8 and 1A10 of the differences in the UGT1A9 Sp1/initiator-like site complex B to UGT1A9 promoter activity by UGT1A8 and 1A10 promoter These results that the in promoter of the and genes is by the of other their promoters. this in regulation the and genes is in their expression UGT1A8 and 1A10 a of expression in that in to are the to be expressed exclusively in extrahepatic B. P.I. PubMed Scopus Google Scholar, C.P. R.H. Mol. Pharmacol. 1997; PubMed Scopus Google Scholar, C.P. R.H. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, A. Tephly T.R. PubMed Scopus Google Scholar). In the expression of UGT1A8 and 1A10 to be in the of the gastrointestinal UGT1A8 and expression has been in the and with in the B. P.I. PubMed Scopus Google Scholar, C.P. R.H. Mol. Pharmacol. 1997; PubMed Scopus Google Scholar, C.P. R.H. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, A. Tephly T.R. PubMed Scopus Google Scholar). In contrast, UGT1A9 is expressed in the liver and extrahepatic its of expression in the gastrointestinal is to the colon T. Clarke D. Burchell B. J. PubMed Scopus Google Scholar, C.P. R.H. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). results in have shown that UGT1A8, 1A9, and 1A10 are expressed in the colon cell is that regions upstream from the promoter studied UGT1A9 expression in the shift that the Sp1/initiator-like site is of overlapping binding sites for Sp1 and an (complex B) 2, and The and of the Sp1/initiator-like site are of initiator which the transcription start site with the sequence A. B. Mol. Biol. 1994; PubMed Scopus Google Scholar). Much accumulated evidence suggests that the range of initiator is on the genes have shown that binding and proteins are able to transcription A. J. Biol. Chem. Full Text PDF PubMed Google Scholar, J. Biol. Chem. 1994; Full Text PDF PubMed Google Scholar). The promoter is to the UGT1A8 and 1A10 promoters in that contains an site that with a binding site for The site was shown to bind Sp1 and the with the binding of to transcription A. J. Biol. Chem. Full Text PDF PubMed Google Scholar). the binding of complex B to the Sp1/initiator-like site, in the of Sp1 was for UGT1A8 promoter activity and However, their similarity in shift with a to for complex that was in this complex The site was in sequence to the binding sites in the promoter N.K. Basu A. J. Biol. Chem. 1992; 267: Full Text PDF PubMed Google Scholar). The sites were to and transcription of the gene in the of a other initiator J. Biol. Chem. 1994; Full Text PDF PubMed Google Scholar). However, to and the binding proteins and that these proteins were in complex B regions have been shown to with the these have been in the of an upstream M.W. PubMed Scopus Google Scholar, M. Mol. Biol. PubMed Scopus Google Scholar, C.P. Chen Full Text PDF PubMed Scopus Google Scholar). is that the complex B are proteins and shift that an upstream Sp1 site was for of the UGT1A8 and 1A10 promoters is that the binding of Sp1 to this site promoter whereas the binding of Sp1 to the Sp1/initiator-like site is for activity. suggests that the in which Sp1 is for activity and that the of each site for Sp1 determine the of this transcription on of Sp1 sites are in the activity and of transcription Although the of is Sp1 in the has been to with of the complex and their binding to initiator J. 1994; PubMed Scopus Google Scholar, 267: PubMed Scopus Google Scholar, A. J. Mol. Biol. 1994; PubMed Scopus Google Scholar, N. D. Chen A. S. A. PubMed Scopus Google Scholar). Sp1 has been shown to with the and transcription through the initiator site E. T. PubMed Scopus Google Scholar). that the Sp1/initiator-like site was on the upstream Sp1 site to promoter activity of this Sp1 site UGT1A8 promoter activity to The upstream Sp1 site was in the UGT1A9 the of the functional Sp1/initiator-like site to the of the Sp1 UGT1A9 transcription was bp from the in the of the functional Sp1/initiator-like site The of UGT1A9 transcription from UGT1A8 and 1A10, located bp of their start These that the Sp1/initiator-like site an role in the of transcription in UGT1A8 and 1A10 and that UGT1A9 be regulated through a initiator The the UGT1A8, 1A9, and 1A10 transcription start sites closely the initiator and the of these sites in transcription to be In we have characterized the UGT1A8, 1A9, and 1A10 gene promoters and that these genes are differentially regulated through an overlapping Sp1/initiator-like element in their promoters. The site has that are of initiator sites including its sequence similarity to the initiator site, its to the transcription start site, and its on an upstream Sp1 site to

References

51